Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gadopentetate dimeglumine (Gd-DTPA), an extracellular intravenous contrast agent, is used in combination with magnetic resonance imaging (MRI) to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on the MRI.
説明 | Gadopentetate dimeglumine (Gd-DTPA), an extracellular intravenous contrast agent, is used in combination with magnetic resonance imaging (MRI) to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on the MRI. |
In vivo | Interstitial MR lymphography with gadopentetate dimeglumine (Gd-DTPA) allows clear visualization of the lymphatic pathway in healthy mice, and no significant difference is found between the two agents. Their rapid kinetics limits the imaging timing window, however, facilitates repeated assessment in a single imaging session [1]. Direct visualization of spilled gastrointestinal gadopentetate dimeglumine helps discriminate ischemic from control rats in this model [2]. |
別名 | Meglumine gadopentetate, SH-L-451A, Gd-DTPA, Gadopentetic acid dimeglumine, Gadopentetic acid dimeglumine salt |
分子量 | 938 |
分子式 | C14H20GdN3O10.2C7H17NO5 |
CAS No. | 86050-77-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90 mg/mL(95.9 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gadopentetate dimeglumine 86050-77-3 Others Meglumine gadopentetate SH-L-451A inhibit Gd-DTPA Inhibitor Gadopentetic acid dimeglumine Gadopentetic acid dimeglumine salt inhibitor